Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 9841 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Pharvaris Announces Extraordinary Meeting of Shareholders

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  Pharvaris GmbH

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  EyePoint Pharmaceuticals, Inc.

Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  Y-mAbs Therapeutics Inc.

Annual General Meeting in ALK-Abelló A/S on 14 March 2024

Read more ››
By: GlobeNewswire - 16 Feb 2024

XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  XOMA Corporation

Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  Hepion Pharmaceuticals, Inc.

Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  Kinnate Biopharma, Inc.

Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  Chromocell Therapeutics Corporation

Arcutis to Report Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  Arcutis Biotherapeutics, Inc.

Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  Autonomix Medical, Inc.

Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  Allogene Therapeutics, Inc.

PetMeds® to Give Away Free Pet Food for a Year to Three Lucky Pet Owners and $1,000 in PetMeds® Credits to Three Local Animal Shelters

Read more ››
By: GlobeNewswire - 16 Feb 2024

Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity Requirement

Read more ››
By: GlobeNewswire - 16 Feb 2024

Mdxhealth Announces Resignation of Board Member

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  MDxHealth, Inc. | MDxHealth B.V. | MDxHealth

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  ImmuCell Corporation

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies

Read more ››
By: GlobeNewswire - 16 Feb 2024
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche Ltd | Hoffmann-La Roche Ltd. (Edmonton)

Astiva Health, Inc. Celebrates Grand Opening of New Activity Center in Los Angeles-Koreatown with Support from Rep. Michelle Steel

Read more ››
By: GlobeNewswire - 16 Feb 2024

CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2024
Related companies:  CASI Pharmaceuticals, Inc.

Pusan National University Researchers Reveal How Diabetes Weakens Gum Defense

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2024

New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC

Read more ››
By: PR Newswire Association LLC. - 16 Feb 2024
Related companies:  Lunit Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑